| Bioactivity | Glucagon (19-29), human is a potent and efficient inhibitor of insulin secretion. | ||||||
| Invitro | Glucagon (19-29), from 0.1 pM to 1 nM, exerts a potent negative inotropic action. The most striking observation is a 45% increase in the amplitude of cell contractility elicited by the combination of 30 nM glucagon with 1 nM Glucagon (19-29)[3]. | ||||||
| Name | Glucagon (19-29), human | ||||||
| CAS | 64790-15-4 | ||||||
| Sequence | Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr | ||||||
| Shortening | AQDFVQWLMNT | ||||||
| Formula | C61H89N15O18S | ||||||
| Molar Mass | 1352.53 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |